Dupilumab leads to reduction of anosmia in patients with severe chronic rhinosinusitis with nasal polyps - 01/02/22
Doi : 10.1016/j.jaci.2021.12.486
Andrew Lane, MD 1, Joaquim Mullol, MD PhD FAAAAI 2, Claire Hopkins, MD PhD 3, Wytske Fokkens, MD PhD 4, Stella Lee, MD 5, Asif Khan, MBBS, MPH 6, Jérôme Msihid 6, Scott Nash 7, Shahid Siddiqui 7, Urvi Mujumdar 8, Siddhesh Kamat 7, Paul Rowe 9, Yamo Deniz 7, Juby Jacob-Nara 9
1 The Department of Otolaryngology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
2 Hospital Clínic, IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Catalonia, Spain
3 Guy's and St Thomas' Hospitals, London, UK
4 Department of Otorhinolaryngology, Amsterdam University Medical Centres, Amsterdam, The Netherlands
5 Harvard Medical School, Brigham and Women's Hospital, Division of Otolaryngology—Head & Neck Surgery, Boston, MA, USA
6 Sanofi, Chilly-Mazarin, France
7 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
8 Sanofi, Cambridge, MA, USA
9 Sanofi, Bridgewater, NJ, USA
434
Le texte complet de cet article est disponible en PDF.Plan
© 2021
Publié par Elsevier Masson SAS.
Vol 149 - N° 2S
P. AB144 - février 2022 Retour au numéro
Article précédent
- Prognostic Factors for Polyp Recurrence in Chronic Rhinosinusitis with Nasal Polyps
- Junqin Bai, Julia Huang, Caroline Price, Samuel Rodeghiero, Lydia Suh, David Conley, Kevin Welch, Robert Kern, Stephanie Smith, Whitney Stevens, Atsushi Kato, Robert Schleimer, Bruce Tan
- Unsupervised Cluster Analysis of Nasal Cytokines During RV Infection Identifies Distinct Immunophenotypes in Both Children and Adults with Allergic Asthma
- Lyndsey Muehling, Peter Heymann, Holly Carper, Deborah Murphy, Joshua Kennedy, Stephen Early, Mauel Soto-Quiros, Lydiana Avila, Lisa Workman, Thomas Platts-Mills, Judith Woodfolk
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?